Treatment Modalities

TCR-T Therapy

T-cell receptor engineered T-cell therapy. Targets intracellular antigens via HLA presentation. Afami-cel approved for synovial sarcoma.

Theranostics

Combined diagnostic imaging and therapy using the same molecular target. Most established for prostate (PSMA) and neuroendocrine (DOTATATE) cancers.

TIL Therapy

Tumor-Infiltrating Lymphocyte therapy. Patient's own immune cells extracted from the tumor, expanded, and reinfused. Lifileucel approved for advanced melanoma.

Tomotherapy

VMAT

Surgical Oncology

Surgical removal of cancer tumors and affected tissue. Often the primary curative modality for solid tumors detected at early stages.

Radiation Therapy

Use of high-energy radiation to destroy cancer cells. Modalities range from conventional photon therapy to proton and carbon ion therapy.

CAR-T Cell Therapy

Treatment using genetically modified T cells expressing a chimeric antigen receptor. Approved for B-cell lymphomas, ALL, and multiple myeloma; emerging for solid tumors.